Jazz Pharmaceuticals plc — Director's Dealing 2014

Feb 12, 2014

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2013-12-31

Reporting Person: Cox Russell J. (EVP & Chief Commercial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-05-20	Ordinary Shares	M	1000	$8.23	Acquired	54024	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-05-20	Incentive Stock Option (right to buy)	$8.23	M	1000	Disposed	2020-08-24	Ordinary Shares (1000)	Direct

Footnotes

F1: Includes 288 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on November 29, 2013.

F2: Of the ordinary shares subject to this incentive stock option, originally granted on August 25, 2010, 28,350 shares vested as of May 20, 2013, 9,350 shares vested as of January 21, 2014, and the remaining 7,500 shares vest in six equal monthly installments from February 21, 2014 to July 21, 2014.